Literature DB >> 4009734

Assessment of the chloracnegenic response induced by 3,4,3',4'-tetrachloroazoxybenzene in mice.

V L Horton, R A Yeary.   

Abstract

Chloracne is a follicular hyperkeratosis produced by exposure to certain halogenated aromatic compounds. The rabbit ear bioassay has been used successfully for testing the acnegenic activity of compounds, but the lack of reference data in this species limits its usefulness in correlating chloracne to other toxic effects such as skin carcinogenesis. In this study, a prototype chloracnegen, 3,4,3',4'-tetrachloroazoxybenzene (TCAOB), was used. Five strains of mice (hairless, rhino, rhino+, DBA/2J, and C57BL/6) were treated topically with 100 microliters of 0.001, 0.01, or 0.1% TCAOB daily for 3-9 wk. Skin and liver histology were performed and hepatic enzyme activities measured. At the 0.001% TCAOB level, induction of hepatic aniline hydroxylase and cytochrome P-450 occurred in the C57BL/6 mice and induction of cytochrome c reductase occurred in the rhino mice. Dose-dependent gross and histologic skin lesions, characteristic of follicular hyperkeratosis, were observed in the rhino and hairless strains at the 0.01% and 0.1% levels. These two strains also had induction of hepatic cytochrome c reductase, cytochrome P-450, and aniline hydroxylase at TCAOB concentrations of 0.01 or 0.1%. These results suggest that the rhino and hairless strains of mice may be useful in the study of chloracne.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009734     DOI: 10.1080/15287398509530648

Source DB:  PubMed          Journal:  J Toxicol Environ Health        ISSN: 0098-4108


  1 in total

1.  Inflammatory and chloracne-like skin lesions in B6C3F1 mice exposed to 3,3',4,4'-tetrachloroazobenzene for 2 years.

Authors:  Yuval Ramot; Abraham Nyska; Warren Lieuallen; Alex Maly; Gordon Flake; Grace E Kissling; Amy Brix; David E Malarkey; Michelle J Hooth
Journal:  Toxicology       Date:  2009-09-06       Impact factor: 4.221

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.